NICE recommends Santen’s Roclanda to treat glaucoma and ocular hypertension
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
Read Moreby Emily Kimber | Oct 21, 2024 | News | 0
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK
Read Moreby John Pinching | Jul 19, 2023 | News | 0
By combining both netarsudil and latanoprost treatment, Roclanda reduces intraocular pressure
Read Moreby John Pinching | Aug 15, 2022 | News | 0
Treatment involves a combination of levofloxacin and dexamethasone for use after cataract surgery
Read Moreby John Pinching | Mar 28, 2022 | News | 0
Digital health boost as new website focuses on dry eye disease, which currently affects one in four people across the UK
Read Moreby Lucy Parsons | Aug 10, 2021 | News | 0
Phase III trials are ongoing in Europe and the US
Read Moreby Anna Smith | Jun 26, 2019 | News | 0
Inherited retinal diseases are ideal candidates for gene therapy because many of the responsible genetic mutations have already been identified.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
